Not Tagged
Not Tagged
['rectal', 'prospect trial']
breaking news at #asco23 from our incredible leader, : prospect trial data showed that neoadjuvant folfox was noninferior to chemoradiotherapy for disease-free survival for people #rectalcancer! don't miss her presentation today at 1:00 p.m. ct. 
The official account of @MSKCancerCenter’s Department of Medicine. Chair/Dept. Head: @debschrag